<DOC>
	<DOCNO>NCT02477384</DOCNO>
	<brief_summary>The aim study conduct prospective randomize trial compare TIPS 8mm expand polytetrafluoroethylene ( ePTFE ) -covered stent endoscopic variceal ligation plus propranolol prevention recurrent esophageal variceal bleeding .</brief_summary>
	<brief_title>8mm-TIPS Versus Endoscopic Variceal Ligation ( EVL ) Plus Propranolol Prevention Variceal Rebleeding</brief_title>
	<detailed_description>For prevention recurrent esophageal variceal bleeding , previous clinical study meta-analysis show patient treat transjugular intrahepatic portosystemic shunt ( TIPS ) low rebleeding rate compare endoscopic therapy . However , TIPS associate high rate portosystemic encephalopathy show survival benefit . TIPS small-diameter may achieve sufficient portal decompression reduce incidence hepatic encephalopathy . The aim study conduct prospective randomize trial compare TIPS 8mm ePTFE-covered stent endoscopic variceal ligation plus propranolol prevention recurrent esophageal variceal bleeding .</detailed_description>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>1 . Cirrhosis 2 . Patients bleed esophageal varix ( ≥5days ≤28days ) 3 . ChildPugh B ChildPugh C≤13 1 . THE presence gastric varix 2 . Noncirrhotic portal hypertension 3 . Portal vein thrombosis 4 . The history hepatic encephalopathy 5 . Total bilirubin ≥51.3 umol/L 6 . Previous treatment TIPS surgery 7 . Proven malignancy include hepatocellular carcinoma 8 . Contraindications TIPS、EVL propranolol 9 . Endstage renal disease renal replacement therapy ; 10 . Cardiorespiratory failure 11 . Pregnancy patient give informed consent endoscopic procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>